Overall median survival was higher in participants taking quizartinib, according to results from QuANTUM-First trial.
Melek Hursid, PharmD, MBA
Advertisement
Articles by Melek Hursid, PharmD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Leading Cause of Meningitis Shifts from S. Pneumoniae to K. Pneumoniae
2
American Pharmacists Month: Evolution of Experiential Learning for Pharmacy Students
3
Pharmacists Improve Diabetes Outcomes Through Continuous Glucose Monitoring Services
4
5 Questions With a Pharmacist: Amina Abubakar From Avant Pharmacy
5
